ASCLEPIUS strengthens phage-therapy research at the Eliava Institute

ASCLEPIUS is a Horizon Europe collaboration led by the Eliava Institute with INRAE, the University of Minho and Intelligentsia Consultants. Running from October 2024 to September 2027, it combines exploratory phage-therapy research targeting Pseudomonas aeruginosa and Staphylococcus aureus with researcher exchanges, training and research-management development. The CORDIS project record describes its objectives and participating institutions.